Human GAPDH quantitates human GAPDH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human GAPDH.
Human GAPDH quantitates human GAPDH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human GAPDH.
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is a catalytic enzyme commonly involved in glycolysis. GAPDH exists as a tetramer of 37 kDa identical subunits and catalyses the reversible reduction of 1.3-bisphosphoglycerate to 3-phosphophate glyceraldehyde in the presence of NADPH. In addition to playing a key role in glycolysis, GAPDH is ubiquitous and has other activities unrelated to its glycolytic function. GAPDH is reported to be involved in the processes of replication of DNA, repair of DNA, export of nuclear RNA, membrane fusion and microtubule aggregation. The studies provide evidence of GAPDH, which plays an essential role in the genetic expression observed in the apoptosis and cell phenotype of age-related neurodegenerative diseases. In addition, GAPDH is involved in other cellular processes ranging from membrane fusion to neuronal apoptosis in cancer. GAPDH is reported to bind to a variety of other proteins, including the amyloid precursor protein, mutations that cause certain forms of Alzheimer's disease (MA) and the polyglutamine tracts of huntingtin, the outliers of which are responsible for Huntington's disease. Associations between GAPDH, l-actin and tubulin have also been reported. Since GAPDH is expressed at high levels in most tissues, it is useful as a control of protein loading in Western transfer analysis.
Sensitivity
Sensitivity of dosage: 0.82 ng/mL.
Measurement range
Dose range: 0.82 to 200 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).
Conjugate
Conjugated: Biotin.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17194959 |
| Specifications |
| Accession number | 38 kDa BFA-dependent substrate; 9 gene protein associated with aging; BARS-38; bb02e05; cb350; cb609; CDABP0047; EC 1.2.1.12; secretory protein of the epididymis Li 278; secretory protein of the epididymis Li 162 eP; fb71f08; fk58c09; G3PD; G3PDH; GAPD; |
| Dose range | 0.82 to 200 ng/mL |
| Sensitivity of the dosage | 0.82 ng/mL |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | O14556, P04406 |
| Gene symbol(s) | GAPDH, GAPDHS |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | GAPDH analysis |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 µl; plasma, 50 µl; serum, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH207RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.